Matches in SemOpenAlex for { <https://semopenalex.org/work/W1596272912> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1596272912 endingPage "3513" @default.
- W1596272912 startingPage "3501" @default.
- W1596272912 abstract "Abstract The growth of a poorly immunogenic methylcholanthrene (MCA)-induced murine (m) sarcoma genetically engineered to secrete human (h) TNF-alpha (MCA-102-hTNF) was studied. MCA-102-hTNF tumor cells were implanted in animals bearing three- or 7-day pulmonary metastases established with the parental line MCA-102-WT (wild type). This model approximates the clinical situation in which patients with metastatic cancer would be vaccinated with autologous tumor genetically modified to stimulate the host immune response. Reduction in the number of pulmonary metastases was occasionally seen but was not consistently reproducible. Other cytokine-producing tumors had either no effect on distant pulmonary metastases (mIL-4, IFN-gamma) or a mild, inconclusive effect similar to hTNF-alpha (mTNF-alpha). Significant growth inhibition of MCA-102-hTNF was noted in animals bearing pulmonary metastases. This inhibition was: 1) tumor specific (regression occurred only in animals bearing pulmonary metastases from the same parental line), 2) TNF specific (it was inhibited by in vivo administration of anti hTNF mAbs), 3) dependent on cellular immunity (immune-depletion with anti-CD4 or CD8 mAbs permitted growth). Tumor-infiltrating lymphocytes (TIL) could not be grown from MCA-102-WT or MCA-102-hTNF tumors nor from MCA-102-WT subcutaneous implants in mice bearing MCA-102-WT pulmonary metastases. However, TIL could be grown from hTNF-secreting tumors implanted in mice bearing MCA-102-WT metastases. These TIL were therapeutic against established lung metastases from the parental tumor in adoptive immunotherapy models. These studies suggest a strategy for using gene modified tumors for the therapy of established cancer." @default.
- W1596272912 created "2016-06-24" @default.
- W1596272912 creator A5004554374 @default.
- W1596272912 creator A5009143213 @default.
- W1596272912 creator A5055951203 @default.
- W1596272912 creator A5059941996 @default.
- W1596272912 creator A5065213314 @default.
- W1596272912 creator A5072133376 @default.
- W1596272912 creator A5085899790 @default.
- W1596272912 date "1994-04-01" @default.
- W1596272912 modified "2023-09-26" @default.
- W1596272912 title "Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha." @default.
- W1596272912 cites W1766643663 @default.
- W1596272912 cites W1913690802 @default.
- W1596272912 cites W1973267500 @default.
- W1596272912 cites W2021107622 @default.
- W1596272912 cites W2091691801 @default.
- W1596272912 cites W2160015737 @default.
- W1596272912 doi "https://doi.org/10.4049/jimmunol.152.7.3501" @default.
- W1596272912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2248454" @default.
- W1596272912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8144931" @default.
- W1596272912 hasPublicationYear "1994" @default.
- W1596272912 type Work @default.
- W1596272912 sameAs 1596272912 @default.
- W1596272912 citedByCount "18" @default.
- W1596272912 countsByYear W15962729122015 @default.
- W1596272912 crossrefType "journal-article" @default.
- W1596272912 hasAuthorship W1596272912A5004554374 @default.
- W1596272912 hasAuthorship W1596272912A5009143213 @default.
- W1596272912 hasAuthorship W1596272912A5055951203 @default.
- W1596272912 hasAuthorship W1596272912A5059941996 @default.
- W1596272912 hasAuthorship W1596272912A5065213314 @default.
- W1596272912 hasAuthorship W1596272912A5072133376 @default.
- W1596272912 hasAuthorship W1596272912A5085899790 @default.
- W1596272912 hasConcept C121608353 @default.
- W1596272912 hasConcept C126322002 @default.
- W1596272912 hasConcept C142724271 @default.
- W1596272912 hasConcept C167672396 @default.
- W1596272912 hasConcept C17991360 @default.
- W1596272912 hasConcept C203014093 @default.
- W1596272912 hasConcept C2777701055 @default.
- W1596272912 hasConcept C2777714996 @default.
- W1596272912 hasConcept C2778326572 @default.
- W1596272912 hasConcept C2778690821 @default.
- W1596272912 hasConcept C502942594 @default.
- W1596272912 hasConcept C71924100 @default.
- W1596272912 hasConcept C8891405 @default.
- W1596272912 hasConceptScore W1596272912C121608353 @default.
- W1596272912 hasConceptScore W1596272912C126322002 @default.
- W1596272912 hasConceptScore W1596272912C142724271 @default.
- W1596272912 hasConceptScore W1596272912C167672396 @default.
- W1596272912 hasConceptScore W1596272912C17991360 @default.
- W1596272912 hasConceptScore W1596272912C203014093 @default.
- W1596272912 hasConceptScore W1596272912C2777701055 @default.
- W1596272912 hasConceptScore W1596272912C2777714996 @default.
- W1596272912 hasConceptScore W1596272912C2778326572 @default.
- W1596272912 hasConceptScore W1596272912C2778690821 @default.
- W1596272912 hasConceptScore W1596272912C502942594 @default.
- W1596272912 hasConceptScore W1596272912C71924100 @default.
- W1596272912 hasConceptScore W1596272912C8891405 @default.
- W1596272912 hasIssue "7" @default.
- W1596272912 hasLocation W15962729121 @default.
- W1596272912 hasOpenAccess W1596272912 @default.
- W1596272912 hasPrimaryLocation W15962729121 @default.
- W1596272912 hasRelatedWork W181678093 @default.
- W1596272912 hasRelatedWork W1996150995 @default.
- W1596272912 hasRelatedWork W2005666125 @default.
- W1596272912 hasRelatedWork W2043331267 @default.
- W1596272912 hasRelatedWork W2047209980 @default.
- W1596272912 hasRelatedWork W2398878426 @default.
- W1596272912 hasRelatedWork W3032907499 @default.
- W1596272912 hasRelatedWork W4360983034 @default.
- W1596272912 hasRelatedWork W2185732136 @default.
- W1596272912 hasRelatedWork W2396811992 @default.
- W1596272912 hasVolume "152" @default.
- W1596272912 isParatext "false" @default.
- W1596272912 isRetracted "false" @default.
- W1596272912 magId "1596272912" @default.
- W1596272912 workType "article" @default.